Christoph Strassler

Title: Christoph Strassler: Innovator in Cardiovascular Therapeutics

Introduction

Christoph Strassler is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for cardiovascular diseases. His work has led to the filing of multiple patents, showcasing his innovative approach to medicine.

Latest Patents

Strassler holds 2 patents related to crystalline forms of perindopril erbumine. These patents disclose two new crystalline forms, δ and ε, which are suitable as therapeutic active substances for medicaments aimed at treating cardiovascular diseases, especially high blood pressure and heart failure. The ε crystalline form is obtained through a specific crystallization process involving MTBE and controlled temperature conditions. This innovative method enhances the efficacy of the drug, providing a significant advancement in cardiovascular treatment options.

Career Highlights

Strassler's career is marked by his dedication to pharmaceutical innovation. He has worked extensively on the crystallization processes that improve the stability and effectiveness of medications. His role at Les Laboratoires Servier has allowed him to collaborate with other experts in the field, further enhancing his contributions to medical science.

Collaborations

Throughout his career, Strassler has collaborated with notable colleagues such as Vit Lellek and Roger Fassler. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Christoph Strassler's work in developing new crystalline forms of perindopril erbumine exemplifies his commitment to improving cardiovascular therapies. His innovative approaches and collaborations continue to impact the field positively.